nach oben

Supportive Care in Cancer

Erschienen in:

27.01.2022 | Original Article

Patient participation in treatment decision-making of prostate cancer: a qualitative study

verfasst von: Shucheng Pan, Jinjiao Mao, Lijuan Wang, Yun Dai, Wei Wang

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Despite increasing development in decision-making strategies for patients with prostate cancer, little is known about patients’ individual experience and perception throughout the decision-making process. The objective of this study was to explore patients’ experiences and perceptions towards treatment decision-making.

Methods

We conducted a qualitative interview study with 30 patients diagnosed with prostate cancer. We transcribed interviews verbatim and inductively identified codes. Thematic analysis was used to develop and refine a codebook that aided in the identification of themes.

Results

Three key themes and nine subthemes emerged, which were as follows: I. less involved in treatment decision-making, (i) passive decisional control, (ii) lack of medical knowledge, and (iii) domination by family members; II. the right to be informed of the disease condition and to choose treatment options, (i) sociocultural influences, (ii) patients believe that they should know the true facts of the disease, and (iii) patient autonomy during treatment; and III. future consideration and advance care planning, (i) fewer future concerns, (ii) advance care planning is poorly understood, and (iii) acceptance of advance care planning.

Conclusion

The study results show that patients with prostate cancer have a diversity of needs to cultivate their ability to make treatment decisions, and healthcare professionals should empower patients, as well as provide decision aids or decision support for patients.

Nur mit Berechtigung zugänglich

Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77(1):38–52CrossRef

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424CrossRef

de Martel C, Georges D, Bray F, Ferlay J, Clifford GM (2020) Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 8(2):e180–e190PubMedCrossRef

Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY et al (2016) Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol 70(5):862–874PubMedCrossRef

Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R et al (2020) Cancer registration in China and its role in cancer prevention and control. Lancet Oncol 21(7):e342–e349PubMedCrossRef

Müller E, Hahlweg P, Scholl I (2016) What do stakeholders need to implement shared decision making in routine cancer care? A qualitative needs assessment Acta Oncol 55(12):1484–1491PubMed

Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R (2010) Implementing shared decision making in the NHS. Bmj. 341:c5146PubMedCrossRef

Gravel K, Légaré F, Graham ID (2006) Barriers and facilitators to implementing shared decision-making in clinical practice: a systematic review of health professionals’ perceptions. Implement Sci 1:16PubMedPubMedCentralCrossRef

Engelhardt D, Michor F. A quantitative paradigm for decision-making in precision oncology. Trends Cancer. 2021.

10.

World Health Organization. Cancer: diagnosis and treatment, (2018).

11.

Scholl I, Hahlweg P, Lindig A, Bokemeyer C, Coym A, Hanken H et al (2018) Evaluation of a program for routine implementation of shared decision-making in cancer care: study protocol of a stepped wedge cluster randomized trial. Implement Sci 13(1):51PubMedPubMedCentralCrossRef

12.

Pagès-Puigdemont N, Mangues MA, Masip M, Gabriele G, Fernández-Maldonado L, Blancafort S et al (2016) Patients’ perspective of medication adherence in chronic conditions: a qualitative study. Adv Ther 33(10):1740–1754PubMedPubMedCentralCrossRef

13.

Giardini A, Maffoni M, Kardas P, Costa E (2018) A cornerstone of healthy aging: do we need to rethink the concept of adherence in the elderly? Patient Prefer Adherence 12:1003–1005PubMedPubMedCentralCrossRef

14.

Maffoni M, Traversoni S, Costa E, Midão L, Kardas P, Kurczewska-Michalak M et al (2020) Medication adherence in the older adults with chronic multimorbidity: a systematic review of qualitative studies on patient’s experience. Eur Geriatr Med 11(3):369–381PubMedCrossRef

15.

Maffoni M, Giardini A. Qualitative studies on medication adherence: what do they add to knowledge gained by quantitative methods? Adherence to Medical Plans for Active and Healthy Ageing 2017. p. 75–102.

16.

Lechner S, Herzog W, Boehlen F, Maatouk I, Saum KU, Brenner H et al (2016) Control preferences in treatment decisions among older adults - results of a large population-based study. J Psychosom Res 86:28–33PubMedCrossRef

17.

Ihrig A, Maatouk I, Friederich HC, Baunacke M, Groeben C, Koch R, et al. The treatment decision-making preferences of patients with prostate cancer should be recorded in research and clinical routine: a pooled analysis of four survey studies with 7169 patients. J Cancer Educ. 2020.

18.

Sekimoto M, Asai A, Ohnishi M, Nishigaki E, Fukui T, Shimbo T et al (2004) Patients’ preferences for involvement in treatment decision making in Japan. BMC Fam Pract 5:1PubMedPubMedCentralCrossRef

19.

Zeng Y, Feng Q, Hesketh T, Christensen K, Vaupel JW (2017) Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: a cohort study. Lancet 389(10079):1619–1629PubMedPubMedCentralCrossRef

20.

Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415–1424PubMedCrossRef

21.

Holtfrerich SKC, Knipper S, Purwins J, Castens J, Beyer B, Schlomm T et al (2020) The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients. Psychooncology 29(8):1338–1346PubMedCrossRef

22.

Ettridge KA, Bowden JA, Chambers SK, Smith DP, Murphy M, Evans SM et al (2018) “Prostate cancer is far more hidden…”: perceptions of stigma, social isolation and help-seeking among men with prostate cancer. Eur J Cancer Care (Engl). 27(2):e12790CrossRef

23.

Taylor KL, Williams RM, Davis K, Luta G, Penek S, Barry S et al (2013) Decision making in prostate cancer screening using decision aids vs usual care: a randomized clinical trial. JAMA Intern Med 173(18):1704–1712PubMedPubMedCentral

24.

Grüne B, Köther AK, Büdenbender B, Michel MS, Kriegmair MC, Alpers GW (2021) Patients’ perspective on shared decision-making in urology: a prospective study at a university hospital. World J Urol. 39:4491–4498PubMedCrossRef

25.

Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H et al (2017) Qualitative study on decision-making by prostate cancer physicians during active surveillance. BJU Int 120(1):32–39PubMedCrossRef

26.

Doveson S, Holm M, Axelsson L, Fransson P, Wennman-Larsen A (2020) Facing life-prolonging treatment: the perspectives of men with advanced metastatic prostate cancer - an interview study. Eur J Oncol Nurs. 49:101859PubMedCrossRef

27.

Oswald LB, Schumacher FA, Gonzalez BD, Moses KA, Penson DF, Morgans AK (2020) What do men with metastatic prostate cancer consider when making treatment decisions? A mixed-methods study. Patient Prefer Adherence 14:1949–1959PubMedPubMedCentralCrossRef

28.

Long X, Wu L, Zeng X, Wu Z, Hu X, Jiang H et al (2020) Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision-making processes. Cancer Med 9(20):7524–7536PubMedPubMedCentralCrossRef

29.

A J, Zhang B, Zhang Z, Hu H, Dong JT (2021) Novel gene signatures predictive of patient recurrence-free survival and castration resistance in prostate cancer. Cancers. 13(4):917PubMedPubMedCentralCrossRef

30.

Connor MJ, Khoo V, Watson V, Ahmed HU (2021) Radical treatment without cure: decision-making in oligometastatic prostate cancer. Eur Urol. 79:558–560PubMedCrossRef

31.

Heidegger M, Stambaugh J, Schmidt DJ (2010) Being and time. State University of New York Press, Albany

32.

Mackey S (2005) Phenomenological nursing research: methodological insights derived from Heidegger’s interpretive phenomenology. Int J Nurs Stud 42(2):179–186PubMedCrossRef

33.

Glaser BG, Strauss AL, Strutzel E (1968) The discovery of grounded theory; strategies for qualitative research. Nursing research (New York). 17(4):364

34.

Chien CH, Chuang CK, Liu KL, Liu HE (2007) The participation experiences of localized prostate cancer patients in the treatment decision-making process. Hu Li Za Zhi 54(1):35–42PubMed

35.

Bian W, Wan J, Tan M, Wu X, Su J, Wang L (2019) Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China. BMJ Open. 9(9):e031020PubMedPubMedCentralCrossRef

36.

Tan WS, Teo CH, Chan D, Ang KM, Heinrich M, Feber A et al (2020) Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed-methods approach. BJU Int 125(5):669–678PubMedPubMedCentralCrossRef

37.

Colaizzi PF. Psychological research as the phenomenologist views it. In: Valle RS, King M, editors. Existential-Phenomenological Alternatives for Psychology: Oxford University Press; 1978. p. 6.

38.

Gotay CC, Holup JL, Pagano I (2002) Ethnic differences in quality of life among early breast and prostate cancer survivors. Psychooncology 11(2):103–113PubMedCrossRef

39.

Zeng G, Zhang JK, Rou KM, Xu C, Cheng YK, Qi GM (1998) Infectious disease surveillance in China. Biomed Environ Sci 11(1):31–37PubMed

40.

Cai L, Zheng LA, He L (2018) The forty years of medical genetics in China. J Genet Genomics 45(11):569–582PubMedCrossRef

41.

Josfeld L, Keinki C, Pammer C, Zomorodbakhsch B, Hübner J (2021) Cancer patients’ perspective on shared decision-making and decision aids in oncology. J Cancer Res Clin Oncol 147(6):1725–1732PubMedPubMedCentralCrossRef

42.

Hoffman RM, Van Den Eeden SK, Davis KM, Lobo T, Luta G, Shan J et al (2018) Decision-making processes among men with low-risk prostate cancer: a survey study. Psychooncology 27(1):325–332PubMedCrossRef

43.

Sidana A, Hernandez DJ, Feng Z, Partin AW, Trock BJ, Saha S et al (2012) Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate 72(1):58–64PubMedCrossRef

44.

Efficace F, Feuerstein M, Fayers P, Cafaro V, Eastham J, Pusic A et al (2014) Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making. Eur Urol 66(3):416–427PubMedCrossRef

45.

Wagland R, Nayoan J, Matheson L, Rivas C, Brett J, Downing A et al (2019) “Very difficult for an ordinary guy”: factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: findings from a UK-wide mixed methods study. Patient Educ Couns 102(4):797–803PubMedCrossRef

46.

Aliberti A, Bada M, Rapisarda S, Natoli C, Schips L, Cindolo L (2019) Adherence to hormonal deprivation therapy in prostate cancer in clinical practice: a retrospective, single-center study. Minerva Urol Nefrol 71(2):181–184PubMedCrossRef

47.

Politi MC, Studts JL, Hayslip JW (2012) Shared decision making in oncology practice: what do oncologists need to know? Oncologist 17(1):91–100PubMedPubMedCentralCrossRef

48.

Hacking B, Scott SE, Wallace LM, Shepherd SC, Belkora J (2014) Navigating healthcare: a qualitative study exploring prostate cancer patients’ and doctors’ experience of consultations using a decision-support intervention. Psychooncology 23(6):665–671PubMedCrossRef

49.

Wuensch A, Tang L, Goelz T, Zhang Y, Stubenrauch S, Song L et al (2013) Breaking bad news in China-the dilemma of patients’ autonomy and traditional norms. A first communication skills training for Chinese oncologists and caretakers. Psychooncology. 22(5):1192–1195PubMedCrossRef

50.

Pun JKH, Cheung KM, Chow JCH, Chan WL. Chinese perspective on end-of-life communication: a systematic review. BMJ Support Palliat Care. 2020.

51.

Fielding R, Hung J (1996) Preferences for information and involvement in decisions during cancer care among a Hong Kong Chinese population. Psycho-oncology (Chichester, England) 5(4):321–329

52.

Tse CY, Chong A, Fok SY (2003) Breaking bad news: a Chinese perspective. Palliat Med 17(4):339–343PubMedCrossRef

53.

Chen LM, Miaskowski C, Dodd M, Pantilat S (2008) Concepts within the Chinese culture that influence the cancer pain experience. Cancer Nurs 31(2):103–108PubMedCrossRef

54.

Gu X, Chen M, Liu M, Zhang Z, Cheng W (2016) End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai. China Support Care Cancer 24(5):2209–2215PubMedCrossRef

55.

Frisell A, Lagergren J, de Boniface J (2016) National study of the impact of patient information and involvement in decision-making on immediate breast reconstruction rates. Br J Surg 103(12):1640–1648PubMedPubMedCentralCrossRef

56.

Laine C, Davidoff F (1996) Patient-centered medicine. A professional evolution. Jama 275(2):152–156PubMedCrossRef

Titel: Patient participation in treatment decision-making of prostate cancer: a qualitative study
verfasst von: Shucheng Pan
Jinjiao Mao
Lijuan Wang
Yun Dai
Wei Wang
Publikationsdatum: 27.01.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 5/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06753-1

“Dear hair loss”—illness perceptions of female patients with chemotherapy-induced alopecia

Original Article

Sexual and fertility-related adverse effects of medicinal treatment for cancer; a national evaluation among medical oncologists

Original Article

Associations of patient-reported care satisfaction with symptom burden and healthcare use in hospitalized patients with cancer

Original Article

Early quality of life outcomes after surgery in head and neck cancer survivors with EORTC QLQ-C30 and EORTC QLQ-HN35 in an Asian tertiary centre

Original Article

Functional status in older patients with lung cancer: an observational cohort study

Original Article

Mapping chemotherapy-induced peripheral neuropathy phenotype and health-related quality of life in patients with cancer through exploratory analysis of multimodal assessment data

Original Article

Neu im Fachgebiet Onkologie

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

14.01.2025
Nierenkarzinom
Nachrichten

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

14.01.2025
Prostatakarzinom
Nachrichten

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

10.01.2025
Mammakarzinom
Nachrichten

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

10.01.2025
Antiemetische Therapie
Nachrichten

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Patient participation in treatment decision-making of prostate cancer: a qualitative study